Baker Charles D. 4

What Happened
Charles D. Baker, a director of UnitedHealth Group (UNH), was granted 343 deferred stock units on April 1, 2026. The Form 4 lists the acquisition as an award/grant (code A) at $0.00 per unit (no cash exchanged on the filing). These units are reported as director compensation rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-04-01 (grant of 343 deferred stock units)
• Reported price: $0.00 per unit on the Form 4 (award/grant)
• Filing date: 2026-04-06 — appears to be filed after the typical 2-business-day Form 4 window (i.e., late filing)
• Shares owned after transaction: not disclosed in the provided filing summary
• Footnote: F1 — these are deferred stock units granted as regular quarterly director compensation; they vest immediately but must be retained until the director leaves the Board.

Context
Deferred stock units are a form of compensation that mirror shares but are held in unit form and typically cannot be converted to cash or sold until specified conditions (here, completion of board service) are met. This grant is routine director compensation and does not by itself signal a buy or sell decision by the director. The late filing is a compliance detail to note; it reflects reporting timing rather than the nature of the transaction.